EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | -89.5% | 513 | -86.1% | 0.00% | -80.0% |
| Q1 2022 | $152,000 | -35.6% | 3,700 | -31.7% | 0.01% | -37.5% |
| Q4 2021 | $236,000 | +122.6% | 5,421 | +156.2% | 0.01% | +166.7% |
| Q3 2021 | $106,000 | +79.7% | 2,116 | +268.0% | 0.00% | -50.0% |
| Q3 2020 | $59,000 | -14.5% | 575 | -54.8% | 0.01% | -62.5% |
| Q4 2019 | $69,000 | -46.5% | 1,271 | -41.7% | 0.02% | -73.3% |
| Q4 2018 | $129,000 | +344.8% | 2,180 | +297.1% | 0.06% | +300.0% |
| Q1 2018 | $29,000 | +625.0% | 549 | +322.3% | 0.02% | +275.0% |
| Q4 2016 | $4,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |